AmpliPhi Biosciences Corporation (NASDAQ:APHB) Files An 8-K Results of Operations and Financial ConditionItem 2.02 Results of Operations and Financial Condition.
As set forth in Exhibit 99.1 of this Current Report on Form 8-K, AmpliPhi Biosciences Corporation had approximately $5.7 million of cash and cash equivalents at December 31, 2016.
Item 7.01 Regulation FD Disclosure.
Attached hereto as Exhibit 99.1 is a copy of a presentation that we intend to utilize in connection with various meetings with securities analysts, investors and others at the Annual J.P. Morgan Healthcare Conference, commencing on January 9, 2017. Exhibit 99.1 is incorporated herein by reference.
This Current Report on Form 8-K and the information in this Item 7.01 is being “furnished” and will not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), nor will it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act.